Fenwick & West represented OrsoBio in the transaction. OrsoBio,Inc. a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, announced raising its $67 million Series...
OrsoBio’s $67 Million Series B Funding Round
Eli Lilly’s $3.2 Billion Acquisition of Morphic Holdings
Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
BioVie’s $21 Common Stock Offering
Sheppard Mullin advised ThinkEquity on the transaction. BioVie Inc executed its $21 million public offering of Common Stock and Warrants. ThinkEquity acted as placement agent in the...
SmartBear’s Acquisition of Reflect Software
Fenwick & West represented Reflect Software in the transaction. A provider of software testing and visibility solutions, SmartBear announced its acquisition of SmartReflect Software, an AI-powered...
Insight Enterprises’ Acquisition of SADA
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
OrsoBio’s $60 Million Series A Financing Round
Fenwick & West represented OrsoBio in the transaction. OrsoBio, Inc. announced its $60 million Series A financing, bringing the total capital raised by the Company to $97 million....
DaySmart’s Acquisition of Sawyer
Fenwick & West represented Sawyer in the transaction. DaySmart Software announced its acquisition of Sawyer, a provider of business management software for the children’s activities end market....
CISCO’s $150 Million Acquisition of Working Group TwoCISCO’s $150 Million Acquisition of Working Group Two
Fenwick & West LLP represented CISCO Systems, Inc. in the transaction. CISCO Systems, Inc. (NASDAQ: CSCO) announced its pending acquisition of Working Group Two (WG2). The acquisition...
Cisco’s Acquisition of Code BGP
Fenwick & West represented CISCO Systems, Inc. in the transaction. CISCO Systems, Inc. (NASDAQ: CSCO) announced it has acquired Code BGP, a privately held BGP monitoring company based...
Novartis AG’s Acquisition of Chinook Therapeutics
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
Morphic Therapeutic’s $276 Million Public Offering
Fenwick represented Morphic Holding, Inc. on the deal. Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment...
Cisco’s Acquisition of Valtix
Fenwick advised Cisco Systems, Inc. on the deal. Cisco Systems, Inc. (NASDAQ: CSCO), a worldwide leader in technology, announced its pending acquisition of Valtix, a privately...